NewCardio Stock Forecast - Simple Moving Average

NWCI Stock  USD 0.0001  0.00  0.00%   
NewCardio Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of NewCardio's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 26th of January 2026 the rsi of NewCardio's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of NewCardio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with NewCardio, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting NewCardio's stock price prediction:
Wall Street Target Price
1.25
Quarterly Revenue Growth
(0.90)
Using NewCardio hype-based prediction, you can estimate the value of NewCardio from the perspective of NewCardio response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of NewCardio on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00.

NewCardio after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of NewCardio to cross-verify your projections.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.

NewCardio Additional Predictive Modules

Most predictive techniques to examine NewCardio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NewCardio using various technical indicators. When you analyze NewCardio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for NewCardio is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

NewCardio Simple Moving Average Price Forecast For the 27th of January

Given 90 days horizon, the Simple Moving Average forecasted value of NewCardio on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.
Please note that although there have been many attempts to predict NewCardio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that NewCardio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

NewCardio Stock Forecast Pattern

Backtest NewCardio  NewCardio Price Prediction  Buy or Sell Advice  

NewCardio Forecasted Value

In the context of forecasting NewCardio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. NewCardio's downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered NewCardio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.0001
Downside
0.0001
Expected Value
0.0001
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of NewCardio stock data series using in forecasting. Note that when a statistical model is used to represent NewCardio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria-9.223372036854776E14
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
The simple moving average model is conceptually a linear regression of the current value of NewCardio price series against current and previous (unobserved) value of NewCardio. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for NewCardio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NewCardio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NewCardio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
0.00010.00010.0001
Details

NewCardio Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as NewCardio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NewCardio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NewCardio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
3 Events / Month
2 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.00
0.00 
0.00  
Notes

NewCardio Hype Timeline

NewCardio is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NewCardio is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on NewCardio is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days.
Check out Historical Fundamental Analysis of NewCardio to cross-verify your projections.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.

NewCardio Related Hype Analysis

Having access to credible news sources related to NewCardio's direct competition is more important than ever and may enhance your ability to predict NewCardio's future price movements. Getting to know how NewCardio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NewCardio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EVARFLombard Medical 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BBALNew York Health 0.00 7 per month 0.00  0.00  0.00  0.00  0.00 
NMRDNemaura Medical 0.35 7 per month 0.00 (0.14) 0.00  0.00  50.00 
LCDXCaliber Imaging Diagnostics 0.00 0 per month 0.00  0.20  0.00  0.00  33.33 
FPMIFluoropharma Medical 0.00 0 per month 0.00  0.12  0.00  0.00  100.00 
RBSHRebus Holdings 0.00 3 per month 0.00  0.00  0.00  0.00  0.00 
WEQLWellQuest Medical Wellness 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LPTILongport 0.00 2 per month 0.00  0.00  0.00  0.00  0.00 
VIVEViveve Medical 0.62 23 per month 0.00  0.12  0.00  0.00  877.78 
SNNAQSienna Biopharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Other Forecasting Options for NewCardio

For every potential investor in NewCardio, whether a beginner or expert, NewCardio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NewCardio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NewCardio. Basic forecasting techniques help filter out the noise by identifying NewCardio's price trends.

NewCardio Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NewCardio stock to make a market-neutral strategy. Peer analysis of NewCardio could also be used in its relative valuation, which is a method of valuing NewCardio by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

NewCardio Market Strength Events

Market strength indicators help investors to evaluate how NewCardio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NewCardio shares will generate the highest return on investment. By undertsting and applying NewCardio stock market strength indicators, traders can identify NewCardio entry and exit signals to maximize returns.

Story Coverage note for NewCardio

The number of cover stories for NewCardio depends on current market conditions and NewCardio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NewCardio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NewCardio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out Historical Fundamental Analysis of NewCardio to cross-verify your projections.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.